CH Emile Roux — Le Puy-en-Velay

Public research footprint of CH Emile Roux, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Critical Illness · Colon Cancer (High-risk Stage III: pT4N1 or pT1 to 4 N2) · Rheumatoid Arthritis (RA) · Migraine

Recently updated registry entries

NCT04573478 — Atrasentan in Patients With IgA Nephropathy (Active Not Recruiting)
NCT06701513 — A Real-world Study to Evaluate the Effectiveness of Deucravacitinib in Adults With Plaque… (Recruiting)
NCT05952167 — Evaluation of the Impact of Tractions vs. Placebo Tractions in Patients With Cervical… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CH Emile Roux?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.